ROSUVASTATIN 10mg. IP + ASPIRIN 75mg. IP

A combination of lipid-lowering and blood-thinning agents is used for the prevention of heart attack and stroke. Blocks the body's ability to produce bad cholesterol and reduces the risk of cardiovascular deaths and events. (Ahai Luvai, 2012) Prevents the platelets from sticking together and decreases the formation of harmful blood clots Exhibits antiplatelet action by inhibiting the cyclooxygenase-1 enzyme from synthesizing thromboxane in platelets thereby reducing platelet aggregation. (Darshana Patel, 2007) A very potent statin, with favorable effects on high-density lipoprotein cholesterol, shows a halt of the atherosclerotic burden and reduces cardiovascular events. (Efthimiadis, 2008) Shows superior low-density lipoprotein (LDL) cholesterol-lowering efficacy as compared to atorvastatin 10 mg and 80 mg. (White, 2002) Produces a more potent and prolonged inhibition of HMG-CoA reductase than other statins. (Pascal Bousquet, 2003) Effectively and rapidly improves the lipid profile in patients with a broad spectrum of dyslipidemias. (Lesley J Scott, 2004) Reduces low-density lipoprotein cholesterol (LDL-C) levels by 52-63%, as well as increases high-density lipoprotein cholesterol (HDL-C) levels by up to 14% and reduces triglycerides (TG) by up to 28%. (Rosenson, 2003)